Does Agilent Technologies (A) Have Attractive Long-Term Growth Prospects?

Cooper Investors, an investment management firm, released its “Cooper Investors Global Equities Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. The fund returned 6.24% in the fourth quarter, compared to a 7.08% return for the benchmark MSCI ACWI. For the year 2022, the fund returned -24.69% compared to a -17.71% return for its benchmark. In addition, please check the fund’s top five holdings to know its best picks in 2022.

Cooper Investors highlighted stocks like Agilent Technologies, Inc. (NYSE:A) in the fourth quarter 2022 investor letter. Headquartered in Santa Clara, California, Agilent Technologies, Inc. (NYSE:A) provides application-focused solutions to laboratories globally. On January 18, 2023, Agilent Technologies, Inc. (NYSE:A) stock closed at $154.07 per share. One-month return of Agilent Technologies, Inc. (NYSE:A) was 3.40%, and its shares gained 10.46% of their value over the last 52 weeks. Agilent Technologies, Inc. (NYSE:A) has a market capitalization of $45.616 billion.

Cooper Investors made the following comment about Agilent Technologies, Inc. (NYSE:A) in its Q4 2022 investor letter:

Agilent Technologies, Inc. (NYSE:A) finished a great year with +12% organic growth after a +15% year in 2021. As a supplier of liquid chromatography/ mass spectrometry instruments into the life sciences industry, Agilent enjoyed a period of super-normal growth over the 2020-2021 COVID pandemic. Like several of our healthcare and diagnostics investments Agilent de-rated quite sharply in the first half of 2022 as the market ‘faded’ the decline in COVID testing revenues. In our view this short term volatility obscures the high quality of Agilent’s business and long term growth opportunities. One example is environmental testing as mandated by the US EPA where US$4bn of funding in the infrastructure bill has been put aside for PFAS testing. As CEO Mike McMullen noted on the last call, ‘it’s the first time in my career we’ve seen this kind of government money coming in’.”

Pressmaster/Shutterstock.com

Agilent Technologies, Inc. (NYSE:A) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. Per our database, 46 hedge fund portfolios held Agilent Technologies, Inc. (NYSE:A) at the end of the third quarter, and 41 in the previous quarter.

We discussed Agilent Technologies, Inc. (NYSE:A) in another article and shared the best genomics stocks to buy. In addition, please check out our hedge fund investor letters Q4 2022 page for more investor letters from hedge funds and other leading investors.

Suggested Articles:

Disclosure: None. This article is originally published at Insider Monkey.